Trial Profile
Bendamustine Containing Fludarabine-Based Reduced Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Refractory/Relapsed Classical Hodgkin Lymphoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Jul 2015
Price :
$35
*
At a glance
- Drugs Bendamustine (Primary) ; Fludarabine
- Indications Hodgkin's disease
- Focus Therapeutic Use
- 31 Jul 2015 New trial record
- 14 Jun 2015 Results presented at the 20th Congress of the European Haematology Association.